Loading company…
Pinwheel Therapeutics develops treatments for emergency anticoagulation reversal.
Pinwheel Therapeutics is a US-based clinical-stage biopharmaceutical company developing treatments for emergency anticoagulation management. Its lead asset, Ciraparantag, is designed to reverse several classes of anticoagulants and is being developed as an intravenous treatment for emergencies including trauma, intracranial hemorrhage and urgent surgery. In February 2026, the company raised USD 20 million from 108 BioCapital and Claypond Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in